OpenAlex
PricingAboutJobs
Log inGet started
Work

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients

HTML

Year: 2016
Type: review
Source: Expert Opinion on Emerging Drugs
DOI: 10.1080/14728214.2016.1241232
Authors: Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, Bruno P. Imbimbo, Madia Lozupone, Antonio Leo, Rodolfo Sardone, Gaetano Gagliardi, Lucia Lofano, Bianca C. Creanza, Paola Bisceglia, Antonio Daniele, Antonello Bellomo, Antonio Greco, Giancarlo Logroscino
Institutions: Casa Sollievo della Sofferenza, University of Bari Aldo Moro, Chiesi (Italy), Università Cattolica del Sacro Cuore, University of Foggia
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, amyloid-beta, anti-amyloid drugs, disease-modifying therapy, BACE inhibitors, verubecestat, solanezumab, gantenerumab, aducanumab, RAGE inhibitors, disodium cromoglycate, ibuprofen, familial Alzheimer's disease, preclinical Alzheimer's disease, tau protein
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2418725963
FWCI: 1.053
Cites: 128
Cited by: 66
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security